1/31/2007 12:04:19 PM
WALTHAM, Mass. and MADISON, Wis.--(BUSINESS WIRE)--Epitome Biosystems and EMD Biosciences Inc. announced today the successful completion of a collaboration to develop multiplex assays to measure phosphorylation of cell signaling proteins using Epitome’s EpiTag™ technology. Epitome developed custom antibody and peptide reagents to enable quantitative protein measurements of selected targets for EMD Biosciences. This completes the first commercial partnership for Epitome. Products resulting from this collaboration will be manufactured, marketed and sold for research applications on a world-wide basis by EMD Biosciences Inc. through its Novagen brand.
comments powered by